To read the Nature Reviews article on Guillain–Barré syndrome, please click here.
Respiratory syncytial virus (RSV) is a highly contagious virus that causes severe respiratory illness, leading to approximately 177,000 hospitalizations and 14,000 deaths annually among adults aged 65 and older [1]. Individuals with weakened immune systems are particularly at risk for severe complications from RSV [2]. RSV vaccines have proven to be highly effective in preventing…
“To our family and friends in the community affected by the California wildfires, our hearts and thoughts are with you during this devastating time. If you are living with GBS, CIDP, MMN, or variant conditions and are facing difficulties accessing medical treatment or need support, please do not hesitate to reach out to the Foundation….
University of Kansas Neuromuscular Review Course January 25, 2025, at the Bellagio Hotel in Las Vegas, Nevada Register now for the Neuromuscular Review Course, presented by leading neurologists specializing in neuromuscular clinical issues related to diagnosing and treating neuromuscular diseases. This program is designed for neurologists, nurse practitioners, physician assistants, trainees, and other HCPs treating…
Speaker Series – Episode 14 Summary In this Speaker Series episode, we talked with Rebecca Aune, Director of Education Programs, and Hayley Mason, Policy Analyst, at the National Organization for Rare Disorders (NORD). This Speaker Series Summary will explore the drug development process and the factors and people that influence it. Resources Learn more about…
VITALIZE (EFC18156) For US Audience Only A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (VITALIZE) The purpose of the study is to evaluate effects and safety of riliprubart compared to IVIg in adult participants with CIDP who…
Mobilize Clinical Trial for CIDP For US Audience Only MOBILIZE (EFC17236) A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work (MOBILIZE) The purpose of this Phase 3 study is to test the effects and safety of riliprubart compared…
Speaker Series – Episode 13 Summary In this Speaker Series episode, we talked with Ms. Kate Costello, a Licensed Nutrition Specialist, Mentor and Wellness coach, about nutrition and how to eat in the face of challenges with our conditions. Resources Learn more about our Patient Registry Explore other Speaker Series Summaries Join a community with…
Bryn Mawr Rehab Foundation Event On September 24, 2024, Bryn Mawr Rehabilitation Hospital in Malvern, PA hosted an Open House for our local patient community. Moderated by Maria Harris, DPT, PT with Main Line Health, the event showcased the state-of-the-art facility and their commitment to creating a comprehensive rehabilitation program for each patient. Attendees were…
University of Alabama at Birmingham (UAB) team joins the Birmingham Walk & Roll event The GBS|CIDP Foundation International team was honored to have the University of Alabama at Birmingham (UAB) team join us for the Birmingham Walk & Roll event. Thanks to Foundation staff member, Lori, for her pivotal role in connecting with Eroboghene Ubogu…
The Big Get Together Article was written by: Claire Shaw, CIDP Patient and GAIN Community Member When Rich asked me whether I wanted to say a few words today about the GBS and CIDP community, it made me wonder precisely how long I’ve been a member of the club that no one wants to be…
Meeting of GBS|CIDP Switzerland University Hospital Balgrist at Zurich On October 26, 2024, around 50 members of the GBS/CIDP Initiative Switzerland gathered at Balgrist University Hospital in Zurich for a valuable event focused on exchange and education. The day provided our members with the opportunity to deepen their knowledge about Guillain-Barré Syndrome (GBS) and Chronic…
Michael Ring, a determined GBS warrior who has turned his personal struggle into an inspiring journey of resilience. Diagnosed with Guillain-Barré Syndrome (GBS), he faced incredible physical challenges that could have ended his marathon dreams. But instead of giving up, he pushed through, reclaiming his strength step by step. Now, he’s sharing his story with…
Speaker Series – Episode 12 Summary In this Speaker Series episode, Dr. Jeffery Allen educates us about the current treatments for GBS, CIDP, and MMN as well as explain current trials and their findings. Dr. Allen is an associate professor of neurology at the University of Minnesota, adjunct faculty at Northwestern University, and the chairman…
The Critical Medicines Alliance The GBS|CIDP Foundation International recently joined the Critical Medicines Alliance, an initiative launched by the European Commission for the next 5 years. The objective of the Alliance is “to serve as a consultative body to identify priorities for action and propose solutions to strengthen the supply of critical medicines in the European Union,…